Wang Zhe, Dai Bo, Tang Xiaohan, Che Zhihui, Hu Fei, Shen Chengying, Wu Wei, Shen Baode, Yuan Hailong
Department of Pharmacy, Air Force Medical Center, PLA, Beijing 100142, China.
College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Pharmaceutics. 2022 Apr 20;14(5):897. doi: 10.3390/pharmaceutics14050897.
The aim of this study was to develop a new drug nanocrystals self-stabilized Pickering emulsion (NSSPE) for improving oral bioavailability of quercetin (QT). Quercetin nanocrystal (QT-NC) was fabricated by high pressure homogenization method, and QT-NSSPE was then prepared by ultrasound method with QT-NC as solid particle stabilizer and optimized by Box-Behnken design. The optimized QT-NSSPE was characterized by fluorescence microscope (FM), scanning electron micrograph (SEM), X-ray diffraction (XRD), and differential scanning calorimetry (DSC). The stability, in vitro release, and in vivo oral bioavailability of QT-NSSPE were also investigated. Results showed that the droplets of QT-NSSPE with the size of 10.29 ± 0.44 μm exhibited a core-shell structure consisting of a core of oil and a shell of QT-NC. QT-NSSPE has shown a great stability in droplets shape, size, creaming index, zeta potential, and QT content during 30 days storage at 4, 25, and 40 °C. In vitro release studies showed that QT-NSSPE performed a better dissolution behavior (65.88% within 24 h) as compared to QT-NC (50.71%) and QT coarse powder (20.15%). After oral administration, the AUC of QT-NSSPE was increased by 2.76-times and 1.38 times compared with QT coarse powder and QT-NC. It could be concluded that NSSPE is a promising oral delivery system for improving the oral bioavailability of QT.
本研究的目的是开发一种新型的药物纳米晶体自稳定Pickering乳液(NSSPE),以提高槲皮素(QT)的口服生物利用度。通过高压均质法制备槲皮素纳米晶体(QT-NC),然后以QT-NC为固体颗粒稳定剂,采用超声法制备QT-NSSPE,并通过Box-Behnken设计进行优化。通过荧光显微镜(FM)、扫描电子显微镜(SEM)、X射线衍射(XRD)和差示扫描量热法(DSC)对优化后的QT-NSSPE进行表征。还研究了QT-NSSPE稳定性、体外释放和体内口服生物利用度。结果表明,QT-NSSPE液滴大小为10.29±0.44μm,呈现出由油核和QT-NC壳组成的核壳结构。在4、25和40℃储存30天期间,QT-NSSPE在液滴形状、大小、乳析指数、zeta电位和QT含量方面表现出良好的稳定性。体外释放研究表明,与QT-NC(50.71%)和QT粗粉(20.15%)相比,QT-NSSPE具有更好的溶解行为(24小时内为65.88%)。口服给药后,QT-NSSPE的AUC与QT粗粉和QT-NC相比分别增加了2.76倍和1.38倍。可以得出结论,NSSPE是一种有前景的口服给药系统,可提高QT的口服生物利用度。